'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and Metronidazole-resistant Trichomonas vaginalis strains

Pharmacological Research

Volumn 46, Issue 5, 2002, Pages 469-472

  Malagoli, Monica ^a   Rossi, Tiziana ^b   Baggio, Andrea ^c   Zandomeneghi, Ginevra ^a   Zanca, Andrea ^d   Casolari, Chiara ^e   Castelli, Mario ^a,e  

^a Institute of Pharmacology   (Italy)

^b Department of Pharmaceutical Sciences ^*  (Italy)

^c Dermatological Clinic   (Italy)

^d CARLO POMA HOSPITAL   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Bacteria; Metronidazole; Resistance; Sulphimidazole; Trichomonas

Indexed keywords

4 NITROIMIDAZOLE; IMIDAZOLE DERIVATIVE; METRONIDAZOLE; SULFAMETHOXAZOLE; SULFIMIDAZOLE; SULFONAMIDE; TRIMETHOPRIM; UNCLASSIFIED DRUG; 1 METHYL 2 ((4 AMINOPHENYL)SULFONYL)AMINO 5 NITROIMIDAZOLE; 1-METHYL-2-((4-AMINOPHENYL)SULFONYL)AMINO-5-NITROIMIDAZOLE; ANTITRICHOMONAL AGENT; NITROIMIDAZOLE DERIVATIVE;

ANAEROBIC GROWTH; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE CULTIVATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRICHOMONAS VAGINALIS; ANIMAL; DRUG RESISTANCE; DRUG SENSITIVITY;

ANIMALS; ANTITRICHOMONAL AGENTS; DRUG RESISTANCE; METRONIDAZOLE; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; SULFONAMIDES; TRICHOMONAS VAGINALIS;

EID: 0036434527     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043661802002074     Document Type: Article

References (25)

1. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11: 300-17.
2. Rein MF. Clinical manifestations of urogenital trichomoniasis in women. In: Honigberg BM, ed. Trichomonads Parasistic in Humans. New York: Springer, 1990: 225-34.
3. Krieger JN. Prostatitis syndromes: Pathophysiology, differential diagnosis and treatment. Sex Transm Dis 1984; 11: 100-12.
4. Krieger JN. Epidemiology and clinical manifestations of urogenital trichomoniasis in men. In: Honigberg BM, ed. Trichomonads Parasistic in Humans. New York: Springer, 1990: 235-45.
5. Krieger JN. Trichomoniasis in men: Old issues and new data. Sex Transm Dis 1995; 22: 83-96.
6. Lossick JG, Kent HL. Trichomoniasis: Trends in diagnosis and management. Am J Obstet Gynecol 1991; 165: 1217-22.
7. Tuttle JO Jr, Holbrook TW, Derrick FC. Interference of human spermatozoal motility by T. vaginalis. J Urol 1977; 118: 1024-5.
8. De Carneri I, Di Re F. Vaginal trichomoniasis and precancerous state of cervix: A preliminary report. J Obstet Gynaecol Br Commonw 1970; 77: 1016-8.
9. Piot P, Plummer FA, Mhalu FS, Lamboray JL, Chin J, Mann JM. AIDS: An international perspective. Science 1988; 239: 573-9.
10. McGrory T, Meysick KC, Lemchuk-Favel T, Garber GE. The interaction of Lactobacillus acidophilus and Trichomonas vaginalis in vitro. J Parasitol 1994; 80: 50-4.
11. McGrory T, Garber GE. Mouse intravaginal infections with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection. Infect Immun 1992; 60: 2375-9.
12. Taylor-Robinson D, Ackers JP. Interaction between Trichomonas vaginalis and other pathogenic microorganisms in the human genital tract. Br J Vener Dis 1984; 60: 330-3.
13. Meri T, Jokiranta TS, Suhonen L, Meri S. Resistance of Trichomonas vaginalis to metronidazole: Report of the first cases from Finland on optimization of in vitro susceptibility testing under various oxygen concentrations. J Clin Microbiol 2000; 38: 763-7.
14. Bertolini A, Castelli M, Borella F, Dall'Asta L, Comini A, Alberti D, Coppi G. Synthesis and biological properties of 1-methyl-2-((4-aminophenyl)-sulfonyl-)amino-5-nitro-imidazole. Boll Chim Farm 1989; 128: 71-3.
15. Castelli M, Baggio G, Ruberto AI, Rossi T, Provvisionato A, Malagoli M, Bossa R, Galatulas I. In vitro activity of sulphimidazole alone and in association with trimethoprim against enteric pathogens. Pharmacol Res 1992; 25: 373-81.
16. Castelli M, Baggio G, Ruberto AI, Rossi T, Provvisionato A, Malagoli M, Bossa R, Galatulas I. In vitro activity of Trimethoprim in association with sulphimidazole against aerobic Gram-negative and Gram-positive microorganisms and clostridia. Chemotherapy 1995; 41: 337-44.
17. Castelli M, Malagoli M, Lupo L, Roffia S, Paolucci F, Cermelli C, Zanca A, Baggio G. Cytotoxicity and probable mechanism of action of sulphimidazole. J Antimicrob Chem 2000; 46: 541-50.
18. Poch F, Levin D, Levin S, Dan M. Modified thioglycolate medium: A simple and reliable means for detection of Trichomonas vaginalis. J Clin Microbiol 1996; 34: 2630-1.
19. Philip A, Carter-Scott P, Rogers C. An agar culture technique to quantitate T. vaginalis from women. J Infect Dis 1987; 155: 304-8.
20. Gelbart SM, Thomason JL, Osypowsky PJ, Kellet AV, James JA, Broekhuizen FF. Growth of Trichomonas vaginalis in commercial culture media. J Clin Microbiol 1990; 28: 962-4.
21. Fouts AC, Kraus SJ. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141: 137-43.
22. Vanelle P, Maldonado J, Gasquet M, Delmas F, Timon-David P, Jentzer O, Crozet MP. Studies on antiparasitic agents: Effect of the lactam nucleus substitution in the 2-position on the in vitro activity of new 5-nitroimidazoles. J Pharm Pharmacol 1991; 43: 735-6.
23. Narcisi EM, Secor WE. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 1996; 40: 1121-5.
24. Salem A, Parnell MJ, Jackson DD. Metronidazole. In: Reeves DS, Philips I, Williams JD, Wise R, eds. Laboratory Methods in Antimicrobial Chemotherapy. Edinburgh: Churchill-Livingstone, 1978: 268-9.
25. Edwards DI. Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chem 1993; 31: 9-20.